The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:

Notices

• NIH Offers Assistance to Phase II HHS SBIR and STTR Awardees through the NIH Commercialization Accelerator Program (CAP) 2017-2018
  National Institutes of Health
   
• Updated Appendix Policy Eliminates Clinical Trial-Related Materials for NIH/AHRQ/NIOSH Applications Submitted to Due Dates on or After January 25, 2018
  National Institutes of Health
   
• Notice of Intent to Renew a Funding Opportunity Announcement for Autoimmunity Centers of Excellence (ACE) Clinical Research Program (UM1)
  National Institute of Allergy and Infectious Diseases
   
• Notice of Correction in Expiration Date for PAR-17-331 "Discovery of Small Molecule Immunomodulators for Cancer Therapy (R01)" 
  National Cancer Institute
   
• Notice of Correction in Expiration Date for PA-17-330 "Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01)"
  National Cancer Institute
   
• Notice of Correction in Expiration Date for PAR-17-438 "Assay development and screening for discovery of chemical probes or therapeutic agents (R01)"
  National Cancer Institute
   
• Notice of Change to Key Dates, PAR-17-242 "Extracellular Vesicles and Substance Use Disorders (R21)" 
  National Institute on Drug Abuse
   
• Notice of Change to Key Dates, PAR-17-250 "Extracellular Vesicles and Substance Use Disorders (R01)"
  National Institute on Drug Abuse
   
• Notice of Change to Expiration Date and Award Information in PAR-17-334 "Synthetic Biology for Engineering Applications (R01)" 
  National Institute of Biomedical Imaging and Bioengineering
   
• Notice of Withdrawal from participation in PA-16-161 "NIH Exploratory/Developmental Research Grant Program (Parent R21)"
  National Institute of Biomedical Imaging and Bioengineering
   
• Notice of Withdrawal from participation in PA-16-040 "Exploratory/Developmental Bioengineering Research Grants (EBRG)(R21)"
  National Institute of Biomedical Imaging and Bioengineering
   
• Notice of Intent to Publish a Funding Opportunity Announcement for Contraception Research Centers Program (U54)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
   
• NICHD Policy on Receipt of Investigator-Initiated Clinical Trials 
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
   
• Notice of NICHD Participation in PAR-17-083 "NIBIB Biomedical Technology Resource Centers (P41)"
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
   
• Notice of Replacement of Funding Opportunity Announcements for NHGRI's Ethical, Legal, and Social Implications of Genomic Research PA-17-323, PA-17-324 and PA-17-325 
  National Human Genome Research Institute
   
• Notice of Information Regarding NOT-HL-17-490 "New Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01)" 
  National Heart, Lung, and Blood Institute
   
• Updates for PAR-16-098 "Cooperative Research Agreements Related to World Trade Center Health Program (U01)" 
  National Institute for Occupational Safety and Health

Requests for Applications

• Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment (U01)
  National Cancer Institute
    
• Pharmacogenomics of Anti-retroviral Therapy in People Who Inject Drugs (R01)
  National Institute on Drug Abuse
   
• HIV-associated neuropathic pain and opioid interaction (R01)
  National Institute on Drug Abuse
   
• Cardiovascular and Pulmonary Research on E-Cigarettes (R01)
  National Heart, Lung, and Blood Institute
  National Cancer Institute
    
• NINR Exploratory Center (P20)
• NINR Center of Excellence (P30)
  National Institute of Nursing Research
   
• National Metabolomics Data Repository (NMDR) (U2C)
• Metabolomic Data Analysis and Interpretation Tools (U01)
  NIH Roadmap Initiatives
   
• Compound Identification Development Cores (U2C)
  NIH Roadmap Initiatives
   
• Stakeholder Engagement and Program Coordination Center (SEPCC) (U2C)
  NIH Roadmap Initiatives
   
• Innovative Adaptations to Simplify Existing Technologies for Manipulation and Analysis of Glycans (U01)
  NIH Roadmap Initiatives
   
• Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions (U01)
  NIH Roadmap Initiatives
   

Program Announcements

• The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R01)
• The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R21)
  National Cancer Institute
    
• Typical and Atypical Patterns of Language and Literacy in Dual Language Learners (R01) 
• Typical and Atypical Patterns of Language and Literacy in Dual Language Learners (R21)
  National Institute on Deafness and Other Communication Disorders
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  
   
• Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01)
  National Human Genome Research Institute
  National Cancer Institute
  National Institute on Aging
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  National Institute on Deafness and Other Communication Disorders
  National Institute of Environmental Health Sciences
  National Institute on Minority Health and Health Disparities 
  National Institute of Neurological Disorders and Stroke
   
• Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03)
  National Human Genome Research Institute
   
• Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21)
  National Human Genome Research Institute
  National Cancer Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  National Institute on Deafness and Other Communication Disorders
  National Institute of Environmental Health Sciences
  National Institute on Minority Health and Health Disparities 
  National Institute of Neurological Disorders and Stroke
   
• Administrative supplements for validation studies of analytical methods for dietary supplements and natural products (Admin. Suppl.)
  Office of Dietary Supplements
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences. 
• Pregnancy in Women with Disabilities (R03)
• Pregnancy in Women with Disabilities (R01)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
   
• NIBIB Exploratory/Developmental Research Grant Program (R21)
  National Institute of Biomedical Imaging and Bioengineering
   
• Point of Care Technologies Research Network: Point of Care Centers (U54)
  
  National Institute of Biomedical Imaging and Bioengineering
  John E. Fogarty International Center
  National Center for Complementary and Integrative Health
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  Office of Behavioral and Social Science Research

Details, including application deadlines, when applicable, are available through the program links above.  To view the full NIH Guide, present and/or past, please visit http://grants1.nih.gov/grants/guide/index.html

Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Linda Meyer at linda-k-meyer@uiowa.edu, Paul Below at paul-below@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu